Form 4: Guardian Pharmacy CEO Gifts 200K Shares to Charity

Fred Burke, CEO of Guardian Pharmacy Services, gifted 200,000 shares of Class A Common Stock to a charitable donor-advised fund.

Summary

• Fred Burke, President and CEO of Guardian Pharmacy Services, disposed of 200,000 shares of Class A Common Stock.
• The transaction occurred on December 4, 2025, and was a bona fide gift to a charitable donor-advised fund (DAF).
• The DAF has agreed to a lock-up period until June 30, 2026, during which it will not sell or transfer the shares.
• The DAF also committed to holding the shares in its account for up to three years from the gift date.
• Following this transaction, Mr. Burke beneficially owns 1,511,845 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The transaction is a charitable gift, which is generally neutral to slightly positive due to philanthropic activity. The lock-up and holding agreements mitigate immediate selling pressure, which is a positive. However, it does represent a reduction in direct insider ownership, albeit for a good cause.

Positives

• Demonstrates philanthropic activity by a key executive, which can reflect positively on corporate social responsibility.
• The lock-up period until June 30, 2026, and the three-year holding agreement by the DAF mitigate immediate selling pressure on the stock from this specific block of shares.

Negatives

• A reduction in direct beneficial ownership by a key executive, even for charitable purposes, could be interpreted by some as a slight decrease in direct personal stake in the company's equity.

Risks

• Potential for future selling pressure on the stock once the lock-up period expires on June 30, 2026, and after the three-year holding agreement concludes, as the DAF may then liquidate the shares.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's operational or financial performance, beyond the future holding and lock-up periods for the gifted shares.

Management Comments

• Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund (the 'DAF').
• The DAF has agreed (i) not to sell or transfer the shares during a lock-up period expiring June 30, 2026, and (ii) to hold the shares in its account for up to three years from the gift date.

Industry Context

This Form 4 filing details an insider transaction, specifically a charitable gift of shares by a key executive. Such transactions are common and generally reflect personal financial planning or philanthropic endeavors rather than direct operational or strategic shifts within the pharmaceutical services industry. The lock-up and holding agreements are standard practices to manage the market impact of large share transfers.

Stakeholder Impact

• Shareholders: The transaction reduces the direct beneficial ownership of a key executive, but the shares are transferred to a charitable fund with holding restrictions, which may prevent immediate market impact.
• Charitable Organizations: The designated charitable donor-advised fund benefits from the gifted shares, enabling its philanthropic activities.

Next Steps

• The charitable donor-advised fund will hold the 200,000 shares until at least June 30, 2026, due to a lock-up agreement.
• The charitable donor-advised fund has agreed to hold the shares for up to three years from the gift date (December 4, 2025).

Key Dates

Recommendation

This Form 4 filing reports a charitable gift of shares by the CEO, not a sale for personal gain. The shares are subject to a lock-up and holding period, mitigating immediate market impact. While it reduces direct insider ownership, it is not indicative of a change in the company's fundamentals or management's confidence. Therefore, a 'hold' recommendation is appropriate as this transaction alone does not warrant a change in investment thesis.

Keywords

Guardian Pharmacy Services, GRDN, Fred Burke, Form 4, Insider Transaction, Stock Gift, Charitable Donation, CEO, Beneficial Ownership, Equity, Lock-up Period